1262133-64-1: Capecitabine 3-O-BDR Impurity
It is an impurity of Capecitabine, which is used for the treatment of breast, colorectal, gastric, and esophageal cancers.
Additional information on CAS 1262133-64-1
Catalogue No.
VE007562
CAS No.
1262133-64-1
Molecular Formula
C20H30FN3O9
Molecular Weight
475.47 g/mol
Parent drug
Capecitabine
IUPAC Name
2′, 3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine ; 3-O-(5-Deoxy-β-D-ribofuranosyl) Capecitabine
Synonyms
N/A
References
Sci-Hub, Ultrasound-assisted dispersive solid-phase microextraction of capecitabine by multi-stimuli responsive molecularly imprinted polymer modified with chitosan nanoparticles followed by HPLC analysis, 10.1007/s00604-020-04345-0. (2020). Retrieved January 2, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1007/s00604-020-04345-0
Status
In-stock
